Oragen Therapeutics
PrivateLast Round
Crowdfunding
Apr 16, 2026
Est. Valuation
$3.9M
Total Funding Raised
$840,000
Company Overview
Oragen Therapeutics is a biotechnology company that develops an oral nucleic acid delivery platform for the treatment of inflammatory bowel diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Oragen Therapeutics Comparables
Compare Oragen Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Particella | 78% | |
| Thalia Therapeutics PLC | 66% | |
| Biora Therapeutics | 63% | |
Oragen Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Crowdfunding | Apr 16, 2026 |
Key People
Founding team and executive leadership
Oragen Therapeutics Investors
Notable investors and investment history
Oragen Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Oragen Therapeutics's valuation, stock price, and market status.